Asterias’s stem cell therapy shows promise in study – Reuters
|
Asterias's stem cell therapy shows promise in study
Reuters Asterias Biotherapeutics Inc said initial data from a small study showed that its lead stem cell therapy could improve mobility in patients paralyzed by a spinal cord injury. The therapy, AST OPC-1, is the first product derived from human embryos to be … |
